IPO - Medirom Healthcare Technologies Inc.
Form Type: CORRESP
Filing Date: 2024-12-09
Corporate Action: Ipo
Type: New
Accession Number: 000110465924126653
Filing Summary: Medirom Healthcare Technologies Inc. requests acceleration of the effectiveness of its Registration Statement on Form F-1 (File No. 333-281771) to 5:30 p.m. Eastern Time on December 9, 2024. The company indicated that confirmation of this acceleration request should be communicated orally to their counsel, Kenji Taneda of Skadden, Arps, Slate, Meagher & Flom LLP. The request is supported by the representative of the underwriters of the upcoming offering, who joined in a separate letter to the SEC.
Document Link: View Document
Additional details:
Registration Statement: Form F-1
Filing Type: CORRESP
Contact Person: Kenji Taneda
Contact Phone: +81-3-3568-2640
Request Time: 5:30 p.m. Eastern Time
Law Firm: Skadden, Arps, Slate, Meagher & Flom LLP
Ceo Name: Kouji Eguchi
Cfo Name: Fumitoshi Fujiwara
Legal Manager Name: Rumiko Yoneyama
Form Type: CORRESP
Filing Date: 2024-12-09
Corporate Action: Ipo
Type: New
Accession Number: 000110465924126654
Filing Summary: Medirom Healthcare Technologies Inc. has requested the acceleration of the effective date of its Registration Statement on Form F-1, filed as File No. 333-281771. ThinkEquity LLC, acting as the representative of the underwriters of the offering, has formally requested that the Registration Statement become effective on December 9, 2024, at 5:30 p.m. ET, or as soon thereafter as feasible. Additionally, on behalf of the underwriters, ThinkEquity notified the SEC regarding the distribution of the Preliminary Prospectus dated December 4, 2024, indicating compliance with the relevant SEC rules.
Document Link: View Document
Additional details:
Registration Statement File No: 333-281771
Preliminary Prospectus Date: 2024-12-04
Underwriter Representative: ThinkEquity LLC
Request Timestamp: 2024-12-09T17:30:00ET
Comments
No comments yet. Be the first to comment!